Predictive Oncology Stock Analysis
| POAI Stock | USD 0.92 0.02 2.22% |
Predictive Oncology is undervalued with Real Value of 1.39 and Hype Value of 0.9. The main objective of Predictive Oncology stock analysis is to determine its intrinsic value, which is an estimate of what Predictive Oncology is worth, separate from its market price. There are two main types of Predictive Oncology's stock analysis: fundamental analysis and technical analysis.
The Predictive Oncology stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Predictive Oncology's ongoing operational relationships across important fundamental and technical indicators.
Predictive | Build AI portfolio with Predictive Stock |
Predictive Stock Analysis Notes
The company has price-to-book ratio of 1.43. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Predictive Oncology recorded a loss per share of 1.13. The entity last dividend was issued on the 29th of October 2019. The firm had 1:20 split on the 24th of April 2023. Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence primarily in the United States. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota. Predictive Oncology operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 30 people. To find out more about Predictive Oncology contact Raymond Vennare at 412 432 1500 or learn more at https://predictive-oncology.com.Predictive Oncology Investment Alerts
| Predictive Oncology generated a negative expected return over the last 90 days | |
| Predictive Oncology has some characteristics of a very speculative penny stock | |
| Predictive Oncology has high historical volatility and very poor performance | |
| Predictive Oncology has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.62 M. Net Loss for the year was (10.86 M) with profit before overhead, payroll, taxes, and interest of 811.51 K. | |
| Predictive Oncology currently holds about 25.39 M in cash with (11.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
| Predictive Oncology has a frail financial position based on the latest SEC disclosures |
Predictive Oncology Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Predictive Oncology previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Predictive Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.8 M.Technical Drivers
As of the 21st of August, Predictive Oncology holds the Risk Adjusted Performance of 0.0018, variance of 14.36, and Coefficient Of Variation of (11,199). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Predictive Oncology, as well as the relationship between them.Predictive Oncology Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Simple Moving Average indicator is calculated by adding the closing price of Predictive Oncology for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Predictive Oncology short-term fluctuations and highlight longer-term trends or cycles.
Predictive Oncology Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Predictive Oncology insiders, such as employees or executives, is commonly permitted as long as it does not rely on Predictive Oncology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Predictive Oncology insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Predictive Oncology Outstanding Bonds
Predictive Oncology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Predictive Oncology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Predictive bonds can be classified according to their maturity, which is the date when Predictive Oncology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Predictive Oncology Predictive Daily Indicators
Predictive Oncology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Predictive Oncology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Predictive Oncology Forecast Models
Predictive Oncology's time-series forecasting models are one of many Predictive Oncology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Predictive Oncology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Predictive Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Predictive Oncology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Predictive shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Predictive Oncology. By using and applying Predictive Stock analysis, traders can create a robust methodology for identifying Predictive entry and exit points for their positions.
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence primarily in the United States. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota. Predictive Oncology operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Predictive Oncology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |